Miri 4-points marker: a low-cost marking device for flanged intrascleral intraocular lens fixation with modified Yamane technique

dc.citation.epage41
dc.citation.spage1
dc.citation.volume2026
dc.contributor.authorWai Yong Zheng
dc.contributor.authorChieng Lee Ling
dc.contributor.authorYap Jun Fai
dc.contributor.authorNurhayati Abdul Kadir
dc.contributor.authorChuah Gim Seah
dc.contributor.authorNurul Afzan Mustapha
dc.contributor.authorLim Lik Thai
dc.contributor.authorChiang Wai Seng
dc.contributor.departmentFaculty of Medicine and Health Sciences
dc.date.accessioned2026-07-21T02:56:31Z
dc.date.issued2026-07-18
dc.description.abstractBackground: Yamane’s flanged intrascleral intraocular lens (IOL) fixation is widely used in eyes without capsular support, but limitations in conventional conjunctival marking may affect surgical precision and consistency. This study compared the clinical outcomes of modified Yamane scleralfixated IOL implantation using the Miri 4-Points Marker versus Castroviejo calipers, assessing visual outcomes and complications between these two approaches. Methods: This retrospective cohort study at a single hospital of Malaysia included 44 eyes operated on between 2024 and 2025. Conjunctival markings were made using either the Miri 4-Points Marker or Castroviejo calipers. Two 30-gauge thin-walled needles created right-angled sclerotomies 2 mm posterior to the limbus. IOL haptics were externalized through the needles, cauterized to form a flange, and inserted into scleral tunnels. Descriptive statistics and binary logistic regression were used to assess factors associated with postoperative visual outcomes. Results: Among 44 patients (mean age 64.4 ± 9.7 years, 77.3% male) who underwent intrascleral IOL fixation, the Miri 4-Points Marker was used in 72.7% of cases. Clinical outcomes with the Miri 4-Points Marker were comparable to Castroviejo calipers. Mean postoperative uncorrected visual acuity (UCVA) and corrected distant visual acuity (CDVA) were 0.7 (± 0.4) and 0.4 (± 0.3) logMAR, respectively. At one month postoperatively, 17.2% achieved good UCVA, increasing to 30.8% after excluding ocular comorbidities; 41.4% achieved good CDVA, rising to 46.2% without ocular comorbidities. On univariable analysis, high corneal astigmatism (>2.5 D) was associated with poorer UCVA across all patients, regardless of Miri 4-Points Marker use (OR = 0.07, 95% CI: 0.01, 0.78, p = 0.03). Multivariable analysis did not identify any independent predictors. Conclusions: The Miri 4-Points Marker is a feasible and safe adjunct for conjunctival marking in Yamane intrascleral IOL fixation. Observed short-term outcomes were similar to caliper-based marking, although this study’s chronological design precludes any conclusion of equivalence.
dc.description.referencesUncontrolled Keywords: Astigmatism, intraocular lens implantation, Yamane SFIOL, Scleral fixated IOL.
dc.description.statusPublished
dc.identifier.citationWai, Y. Z., Chieng, L. L., Yap, J. F., Abdul Kadir, N., Chuah , G. S., Mustapha, N. A., Lim, L. T., & Chiang, W. S. (2026). Miri 4-points marker: a low-cost marking device for flanged intrascleral intraocular lens fixation with modified Yamane technique. BMC Ophthalmology, 2026, 1–41. https://doi.org/10.1186/s12886-026-05134-8
dc.identifier.doihttps://doi.org/10.1186/s12886-026-05134-8
dc.identifier.emailltlim@unimas.my
dc.identifier.issn1471-2415
dc.identifier.urihttps://link.springer.com/article/10.1186/s12886-026-05134-8
dc.identifier.urihttps://scholarhub.unimas.my/handle/123456789/1229
dc.publisherSpringer Nature
dc.relation.ispartofBMC Ophthalmology
dc.titleMiri 4-points marker: a low-cost marking device for flanged intrascleral intraocular lens fixation with modified Yamane technique
dc.typeArticles
dc.type.statusYes

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
s12886-026-05134-8_reference_260721_005027.pdf
Size:
3.74 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections